HTF Market Intelligence released a new research report of 54 pages on title 'Traveler's Diarrhea - Pipeline Review, H2 2016 ' with detailed analysis, forecast and strategies.
Traveler's Diarrhea - Pipeline Review, H2 2016’, provides an overview of the Traveler's Diarrhea pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Traveler's Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in therapeutic development for Traveler's Diarrhea and features dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
- The report provides a snapshot of the global therapeutic landscape of Traveler's Diarrhea
- The report reviews pipeline therapeutics for Traveler's Diarrhea by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Traveler's Diarrhea therapeutics and enlists all their major and minor projects
- The report assesses Traveler's Diarrhea therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Traveler's Diarrhea
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Global Markets Direct Report Coverage 6
Traveler's Diarrhea Overview 7
Therapeutics Development 8
Pipeline Products for Traveler's Diarrhea - Overview 8
Pipeline Products for Traveler's Diarrhea - Comparative Analysis 9
Traveler's Diarrhea - Therapeutics under Development by Companies 10
Traveler's Diarrhea - Therapeutics under Investigation by Universities/Institutes 11
Traveler's Diarrhea - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Traveler's Diarrhea - Products under Development by Companies 15
Traveler's Diarrhea - Products under Investigation by Universities/Institutes 16
Traveler's Diarrhea - Companies Involved in Therapeutics Development 17
Cosmo Pharmaceuticals NV 17
GlaxoSmithKline Plc 18
Nippon Shinyaku Co., Ltd. 19
Prokarium Limited 20
Scandinavian Biopharma Holding AB 21
Sigmoid Pharma Limited 22
Traveler's Diarrhea - Therapeutics Assessment 23...................
Reasons to access
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Traveler's Diarrhea
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Traveler's Diarrhea pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Category: Market Research Publishers and RetailersCompany about: HTF Market Report is wholly owned brand of HTF market Intelligence Consulting Private Limited which provides next-generation service for organizations with a deep focus on market intelligence, data analytics, and social intelligence, all uniquely delivered under one roof by skilled professionals. By combining and analyzing acquire lucid and most relevant data which would help in better decision-making. We provide your requirements with speed and cost benefit across the world, we are able to achi ...
For more information:Make an Inquiry about this report HERE!